Loading…
Based on limited metadata available, the FDA issued a Warning Letter to Haloderm, Inc., a drug manufacturer, on October 6, 2020. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the metadata provided. The warning falls under FDA's drug regulation authority, though the specific issuing office is not identified in the available information. Additional details about the company's manufacturing practices, product quality, or compliance issues would require review of the complete Warning Letter.